---
figid: PMC4964743__khvi-12-03-1102809-g003
figlink: /pmc/articles/PMC4964743/figure/f0003/
number: Figure 3
caption: 'Regulation of HER3 and downstream signaling. HER3/ERBB3 adopts an active
  conformation following binding of a ligand, called neuregulin (NRG), in between
  domains I and III of the extracellular domain. Since the tyrosine kinase domain
  is impaired, HER3/ERBB3 can undergo only weak auto-phosphorylation. In addition,
  HER3/ERBB3 can form heterodimers with other receptor tyrosine kinases (RTKs), leading
  to efficient trans-phosphorylation of the cytoplasmic domain. The main dimerization
  partner of HER3 is HER2/ERBB2 . Both the MAPK pathway (ERK, shown in purple) and
  the AKT pathway (gray) are activated when such heterodimers form. Nuclear translocation
  of the downstream effectors of these pathways permits transcriptional and translational
  regulation of genes involved in numerous cellular responses, such as cell cycle
  control, proliferation, survival, metabolism, apoptosis and angiogenesis. On its
  own, HER3 is regulated at different levels: 2 ubiquitin ligases, NEDD4 and NRDP1,
  have been reported to mediate its ubiquitination and proteosomal degradation. The
  deubiquitinating enzyme USP8, which is regulated by AKT, negatively regulates NRDP1.
  The activated androgen receptor (AR) also controls HER3 levels by binding to the
  NRDP1 promoter regions and activating NRDP1 transcription. In addition, several
  miRNA molecules, such as miR205, miR125a and miR125b, have been reported to control
  HER3/ERBB3 expression.'
pmcid: PMC4964743
papertitle: Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.
reftext: Nad√®ge Gaborit, et al. Hum Vaccin Immunother. 2016 Mar;12(3):576-592.
pmc_ranked_result_index: '58692'
pathway_score: 0.9740881
filename: khvi-12-03-1102809-g003.jpg
figtitle: Regulation of HER3 and downstream signaling
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4964743__khvi-12-03-1102809-g003.html
  '@type': Dataset
  description: 'Regulation of HER3 and downstream signaling. HER3/ERBB3 adopts an
    active conformation following binding of a ligand, called neuregulin (NRG), in
    between domains I and III of the extracellular domain. Since the tyrosine kinase
    domain is impaired, HER3/ERBB3 can undergo only weak auto-phosphorylation. In
    addition, HER3/ERBB3 can form heterodimers with other receptor tyrosine kinases
    (RTKs), leading to efficient trans-phosphorylation of the cytoplasmic domain.
    The main dimerization partner of HER3 is HER2/ERBB2 . Both the MAPK pathway (ERK,
    shown in purple) and the AKT pathway (gray) are activated when such heterodimers
    form. Nuclear translocation of the downstream effectors of these pathways permits
    transcriptional and translational regulation of genes involved in numerous cellular
    responses, such as cell cycle control, proliferation, survival, metabolism, apoptosis
    and angiogenesis. On its own, HER3 is regulated at different levels: 2 ubiquitin
    ligases, NEDD4 and NRDP1, have been reported to mediate its ubiquitination and
    proteosomal degradation. The deubiquitinating enzyme USP8, which is regulated
    by AKT, negatively regulates NRDP1. The activated androgen receptor (AR) also
    controls HER3 levels by binding to the NRDP1 promoter regions and activating NRDP1
    transcription. In addition, several miRNA molecules, such as miR205, miR125a and
    miR125b, have been reported to control HER3/ERBB3 expression.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - NRG2
  - NRG1
  - AR
  - PIK3R5
  - SHC1
  - PTEN
  - MAPK1
  - MAPK3
  - FOXO4
  - GRB2
  - ARAF
  - PIK3R6
  - USP8
  - AKT1
  - AKT2
  - SOS2
  - RNF41
  - NRG3
  - FOXO6
  - PIK3CA
  - FOXO3
  - RAF1
  - BRAF
  - FOXO1
  - SOS1
  - AKT3
  - NEDD4
  - MTOR
  - SHC3
  - PIK3CB
  - PIK3CD
  - NRG4
  - PIK3R3
  - KRAS
  - NRAS
  - SHC2
  - HRAS
  - MAP2K2
  - ERBB2
  - SHC4
  - MAP2K1
  - PIK3CG
  - ERBB3
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: NRG
  symbol: NRG
  source: bioentities_symbol
  hgnc_symbol: NRG2
  entrez: '9542'
- word: NRG
  symbol: NRG
  source: bioentities_symbol
  hgnc_symbol: NRG1
  entrez: '3084'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: USP8
  symbol: USP8
  source: hgnc_symbol
  hgnc_symbol: USP8
  entrez: '9101'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: NRDP1
  symbol: NRDP1
  source: hgnc_alias_symbol
  hgnc_symbol: RNF41
  entrez: '10193'
- word: NRG
  symbol: NRG
  source: bioentities_symbol
  hgnc_symbol: NRG3
  entrez: '10718'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: NEDD4
  symbol: NEDD4
  source: hgnc_symbol
  hgnc_symbol: NEDD4
  entrez: '4734'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: NRG
  symbol: NRG
  source: bioentities_symbol
  hgnc_symbol: NRG4
  entrez: '145957'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: HER3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
